| Bioactivity | Dual Galectin-3/EGFR-IN-1 (Compound 29) is the dual inhibitor for Galectin-3 and EGFR with the KD of 52.29 μM and 3.31 μM. Dual Galectin-3/EGFR-IN-1 inhibits TGF-β-induced hepatic stellate cell (HSCs) activation, induces apoptosis in LX-2 cell, and exhibits anti-liver fibrotic efficacy[1]. |
| Formula | C32H41N7O10 |
| Molar Mass | 683.71 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Liu S, et al., Design and Synthesis of Dual Galectin-3 and EGFR Inhibitors Against Liver Fibrosis. Chem Asian J. 2025 Jan 17;20(2):e202401078. |
Dual Galectin-3/EGFR-IN-1
CAS: F: C32H41N7O10 W: 683.71
Dual Galectin-3/EGFR-IN-1 (Compound 29) is the dual inhibitor for Galectin-3 and EGFR with the KD of 52.29 μM and 3.31
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.